Tuckerman Rehab: Chemical Restraint Concerns Found - MD
Federal inspectors cited Tuckerman Rehabilitation and Healthcare Center on November 5, 2025, after finding that a resident with Alzheimer's disease had been placed on quetiapine, an antipsychotic typically prescribed for schizophrenia and bipolar disorder, and lorazepam, a sedative in the benzodiazepine family. Neither drug had adequate behavior monitoring documentation behind it. The lorazepam had no stop date at all.
The nurse who had administered the medications, identified in the inspection report as RN #2, told inspectors the quetiapine kept the resident from pulling and biting staff and helped the resident stay in bed. When an inspector asked her directly whether that amounted to chemically restraining the resident, she said she had that concern. She said she thought it was better because the resident could participate in the community.
That answer did not resolve the question. It raised it.
The Director of Nursing told inspectors on November 4 that she expected nurses to document the behaviors prompting any as-needed medication before giving it, and that staff should attempt non-pharmacological approaches first. She also said, plainly, that Alzheimer's disease was not an appropriate diagnosis to justify the quetiapine prescription. She agreed the lorazepam order should have carried a 14-day stop date. It didn't have one.
She said she would review the resident's record and get back to the surveyor.
She came back the next morning without the documentation. On November 5, the Director of Nursing told inspectors she could not find records showing the resident had been adequately monitored for the quetiapine. She also could not locate the behavior documentation for the lorazepam.
What she did have was a written statement from RN #2, submitted after the inspection was already underway, in which the nurse said she felt she had not explained herself well to the surveyor. Inspectors noted that the statement came only after their intervention.
There was one more problem. When the resident was admitted, staff had obtained a signed consent form stating that all non-pharmacological interventions had already been exhausted. The Director of Nursing agreed, when pressed, that signing such a form at the moment of admission was not appropriate. A resident arriving at a facility for the first time cannot have already exhausted every behavioral alternative the facility might offer.
The inspection cited the deficiency under F0605, which covers the use of unnecessary drugs, at a level of minimal harm or potential for actual harm, affecting a few residents. The findings were reviewed with the Nursing Home Administrator that same afternoon.
What the record shows is a resident on two sedating medications, one of them prescribed for a diagnosis the facility's own nursing director called inappropriate, the other carrying no expiration date, with no documentation that staff had tracked the resident's behavior before giving either drug, and a consent form that pre-emptively declared all other options exhausted before the resident had spent a single day inside the building.
RN #2 said the resident could participate in the community. The inspection report does not say what participating in the community looked like for a resident kept in bed by medication, or whether anyone had asked.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Tuckerman Rehabilitation and Healthcare Center from 2025-11-05 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 22, 2026 · Our methodology
TUCKERMAN REHABILITATION AND HEALTHCARE CENTER in NORTH BETHESDA, MD was cited for violations during a health inspection on November 5, 2025.
Neither drug had adequate behavior monitoring documentation behind it.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.